文献速递关节外科

芬兰关节登记数据:初次全髋置换中约束型髋臼装置的植入物生存率

Implant Survival of Constrained Acetabular Device in Primary Total Hip Arthroplasty Based on Data From the Finnish Arthroplasty Register.
PubMed 文献 · J Arthroplasty · 2019-08-17

基于芬兰关节登记数据,纳入2006至2017年373例使用约束型髋臼装置的初次全髋置换,按1:3匹配年龄、性别和诊断选取1118例常规全髋置换作为对照。以任何原因翻修为终点,约束装置组8年生存率为94%(CI 91-96),对照组为93%(CI 89-97);前1.5年翻修风险相似(HR 1.09,CI 0.57-2.07,P=.8)。结论认为约束型髋臼装置在初次全髋置换中生存良好,结果支持其继续使用。

要点

  • 约束装置组8年任何原因生存率94%(CI 91-96),对照组93%(CI 89-97)。
  • 无菌性翻修终点8年生存率约束组97%(CI 95-99),对照组94%(CI 90-98)。
  • 前1.5年翻修风险与对照组相似(HR 1.09,CI 0.57-2.07,P=.8)。

核心结论

  • 约束型髋臼装置在初次全髋置换中生存良好,结果支持其继续使用,即使在高风险患者中亦如此。

研究设计与样本

  • 基于芬兰关节登记数据的匹配队列研究,纳入2006至2017年373例使用约束型髋臼装置的初次全髋置换。
  • 按1:3匹配年龄、性别和诊断选取1118例常规全髋置换作为对照组。
  • 以死亡为竞争风险,评估以任何原因翻修和任何无菌性原因为终点的植入物生存率。
  • Cox多元回归模型校正年龄、性别和诊断。
  • 约束装置组平均随访3.3(0-12.4)年,对照组3.8(0-12.0)年。

主要发现

  • 约束装置组共21例翻修,对照组共49例翻修。
  • 8年任何原因生存率:约束装置组94%(CI 91-96) vs 对照组93%(CI 89-97)。
  • 8年无菌性翻修生存率:约束装置组97%(CI 95-99) vs 对照组94%(CI 90-98)。
  • 前1.5年内约束装置组翻修风险与对照组相似(HR 1.09,CI 0.57-2.07,P=.8)。

临床怎么用

  • 作者认为,基于本研究结果,约束型髋臼装置在初次全髋置换中可继续使用,即使在高风险患者中亦如此。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Constrained acetabular devices were developed to prevent dislocations after total hip arthroplasty (THA). However, the data on their success have been contradictory. In this study, we aimed to assess implant survival of the constrained acetabular device in primary THA based on the Finnish Arthroplasty Register data. METHODS: A total of 373 primary THAs with constrained acetabular devices inserted from 2006 to 2017 were included. A reference group was formed on a 1:3 basis and matched for age, sex, and diagnosis, consisting of 1118 conventional THAs. Implant survival estimates using death as a competing risk were assessed with revision for any reason and for any aseptic reason as the endpoints. The Cox multiple regression models were adjusted for age, sex, and diagnosis. The mean follow-up time was 3.3 (0-12.4) years for the constrained device group and 3.8 (0-12.0) years for the reference group. RESULTS: Overall, there were 21 revisions in the constrained device group and 49 in the reference group. The 8-year survivorship for any reason was 94% (confidence interval [CI]: 91-96) for the constrained device group and 93% (CI: 89-97) for the reference group. With revision for any aseptic reason as the endpoint, the 8-year survivorships were 97% (CI: 95-99) and 94% (CI: 90-98), respectively. During the first 1.5 years, the constrained acetabular device group had a similar revision risk (hazard ratio: 1.09 [CI: 0.57-2.07], P = .8) to that of the reference group. CONCLUSION: The constrained acetabular device had good survival in primary THA, and our results support its continued use even in high-risk patients.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Karvonen M, Laaksonen I, Pulkkinen P, et al. Implant Survival of Constrained Acetabular Device in Primary Total Hip Arthroplasty Based on Data From the Finnish Arthroplasty Register. J Arthroplasty. 2019. PMID: 31526699. doi:10.1016/j.arth.2019.08.027

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。